NCT06031441
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06031441
Title A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | CAN | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham (UAB) Birmingham Alabama 35233 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Icahn School of Medicine at Mount Sinai (ISMMS) New York New York 10029 United States Details
The Ohio State University Columbus Ohio 43221-3502 United States Details
Magee-Woman's Hospital Harrisburg Pennsylvania 17109 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
St Vincent's Hospital Sydney Darlinghurst New South Wales 2010 Australia Details
Peter Maccallum Cancer Centre Melbourne Victoria 3000 Australia Details
British Columbia Cancer Agency - 600 10th Ave W Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1Z5 Canada Details
National University Hospital Singapore 119074 Singapore Details
National Cancer Centre Singapore 168583 Singapore Details
Addenbrooke's Hospital Cambridge CB2 0QQ United Kingdom Details
Leicester Royal Infirmary Leicester LE1 5WW United Kingdom Details
St Bartholomew's Hospital London EC1A 7BE United Kingdom Details
Sarah Cannon Research Institute London W1G 6AD United Kingdom Details
Churchill Hospital Oxford OX3 7LJ United Kingdom Details
The Royal Marsden hospital Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field